- Home
- TWO vs ORIC Comparison
TWO vs ORIC Comparison
Compare TWO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWO
- ORIC
- Stock Information
- Founded
- TWO 2009
- ORIC 2014
- Country
- TWO United States
- ORIC United States
- Employees
- TWO N/A
- ORIC N/A
- Industry
- TWO Real Estate Investment Trusts
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- TWO Real Estate
- ORIC Health Care
- Exchange
- TWO Nasdaq
- ORIC Nasdaq
- Market Cap
- TWO 1.1B
- ORIC 1.1B
- IPO Year
- TWO 2009
- ORIC 2020
- Fundamental
- Price
- TWO $9.66
- ORIC $14.10
- Analyst Decision
- TWO Buy
- ORIC Strong Buy
- Analyst Count
- TWO 8
- ORIC 8
- Target Price
- TWO $12.50
- ORIC $16.57
- AVG Volume (30 Days)
- TWO 1.9M
- ORIC 1.6M
- Earning Date
- TWO 10-27-2025
- ORIC 11-11-2025
- Dividend Yield
- TWO 16.18%
- ORIC N/A
- EPS Growth
- TWO N/A
- ORIC N/A
- EPS
- TWO N/A
- ORIC N/A
- Revenue
- TWO $257,735,000.00
- ORIC N/A
- Revenue This Year
- TWO N/A
- ORIC N/A
- Revenue Next Year
- TWO N/A
- ORIC N/A
- P/E Ratio
- TWO N/A
- ORIC N/A
- Revenue Growth
- TWO N/A
- ORIC N/A
- 52 Week Low
- TWO $9.50
- ORIC $3.90
- 52 Week High
- TWO $14.28
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- TWO 42.15
- ORIC 74.62
- Support Level
- TWO $9.60
- ORIC $11.13
- Resistance Level
- TWO $10.22
- ORIC $12.13
- Average True Range (ATR)
- TWO 0.17
- ORIC 0.79
- MACD
- TWO -0.02
- ORIC 0.33
- Stochastic Oscillator
- TWO 9.68
- ORIC 85.09
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.